A novel compound RS-0466 reverses -amyloid-induced cytotoxicity through the Akt signaling pathway in vitro

Author： Nakagami Y.   Nishimura S.   Murasugi T.   Kubo T.   Kaneko I.   Meguro M.   Marumoto S.   Kogen H.   Koyama K.   Oda T.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.457, Iss.1, 2002-12, pp. : 11-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Palmitoylethanolamide Regulates Production of Pro-Angiogenic Mediators in a Model of &bgr; Amyloid-Induced Astrogliosis In Vitro

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 7, 2015-01 ,pp. : 828-837

Bentham Science Publishers

Access to resources Recommend Favorite

The Novel VEGF121-VEGF165 Fusion Attenuates Angiogenesis and Drug Resistance via Targeting VEGFR2-HIF-1-VEGF165/Lon Signaling Through PI3K-AKT-mTOR Pathway

By  

Current Cancer Drug Targets, Vol. 16, Iss. 3, 2016-03 ,pp. : 275-286

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-arthritic effects of clematichinenoside (AR-6) on PI3K/Akt signaling pathway and TNF-α associated with collagen-induced arthritis

By Han Wang   Xiong Ying   Li Yunman   Fang Weirong   Ma Yan   Liu Lifang   Li Fengwen   Zhu Xingxiang  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 51, Iss. 1, 2013-01 ,pp. : 13-22

Informa Healthcare

Access to resources Recommend Favorite

Icariin delays homocysteine-induced endothelial cellular senescence involving activation of the PI3K/AKT-eNOS signaling pathway

By Xiao-Hong Duan   Chang-Qin Xu   Jian-Hua Huang   Wen-Jiang Zhou   Bing Sun  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 51, Iss. 4, 2013-04 ,pp. : 433-440

Informa Healthcare

Access to resources Recommend Favorite

The MEK1/2 inhibitor U0126 reverses imatinib resistance through down-regulating activation of Lyn/ERK signaling pathway in imatinib–resistant K562R leukemia cells

By Shi R.   Lin J.   Guo Y.   Gong Y.P.  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 5, 2014-05 ,pp. : 346-352

Govi-Verlag

Access to resources Recommend Favorite